<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03643146</url>
  </required_header>
  <id_info>
    <org_study_id>17-01791</org_study_id>
    <nct_id>NCT03643146</nct_id>
  </id_info>
  <brief_title>Providing Personalized Health and Individual Lifestyle Enhancing Solutions (Prophiles) in CVD</brief_title>
  <official_title>Providing Personalized Health and Individual Lifestyle Enhancing Solutions (Prophiles) in Cardiovascular Disease (CVD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the proposed project is to evaluate the usability, acceptability, and
      adherence of a lifestyle and behavioral self-tracking and ePersuasive tool aimed at
      improving: 1) adherence to diet/nutrition (&lt;1500 mg of sodium/day and less than 10% daily
      free sugar intake), physical activity (PA) (150 minutes of moderate PA/week), and sleep
      guidelines (7-8 hours of sleep/day)-- and 2) control 3% reduction in systolic BP and glucose
      from baseline to end of study follow-up after 2 months (exploratory objective) in a sample of
      20 patients with Hypertension or Diabetes. The study will utilize a Step-Wedge Design where
      the 20 patients will be divided into 4 wedges (5 patients in each wedge).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 31, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>User Acceptance measured by adherence to diet and nutrition using the Healthy Eating Survey</measure>
    <time_frame>12 Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Measure of physical activity by the International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>12 Months</time_frame>
    <description>Used to assess physical activity and calculate metabolic equivalent</description>
  </primary_outcome>
  <number_of_arms>20</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Wedge 1- Step 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 1-Step 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 1-Step 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 1-Step 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 1-Step 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 2- Step 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 2-Step 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 2-Step 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 2-Step 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 2-Step 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 3-Step 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 3- Step 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 3- Step 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 3- Step 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 3- Step 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 4-Step 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 4- Step 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 4-Step 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 4-Step 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wedge 4-Step 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle Management</intervention_name>
    <description>Will use passive ubiquitous sensing through FitBit to 1)learn behavioral profiles of subjects who have pre-HTN/HTN and/or pre-diabetes /Diabetes 2) provide personalized recommendations through mobile based messaging app that will increase the likelihood of engaging in health diet/nutrition, physical activity and sleep practices</description>
    <arm_group_label>Wedge 1-Step 2</arm_group_label>
    <arm_group_label>Wedge 1-Step 3</arm_group_label>
    <arm_group_label>Wedge 1-Step 4</arm_group_label>
    <arm_group_label>Wedge 1-Step 5</arm_group_label>
    <arm_group_label>Wedge 2-Step 3</arm_group_label>
    <arm_group_label>Wedge 2-Step 4</arm_group_label>
    <arm_group_label>Wedge 2-Step 5</arm_group_label>
    <arm_group_label>Wedge 3- Step 4</arm_group_label>
    <arm_group_label>Wedge 3- Step 5</arm_group_label>
    <arm_group_label>Wedge 4-Step 4</arm_group_label>
    <arm_group_label>Wedge 4-Step 5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control Group</intervention_name>
    <description>will receive standard medical care where research assistant will give pamphlets, with one size fits all recommendations for diet/nutrition, physical activity and sleep, to 10 subjects with comorbid HTN and T2D.</description>
    <arm_group_label>Wedge 1- Step 1</arm_group_label>
    <arm_group_label>Wedge 2- Step 1</arm_group_label>
    <arm_group_label>Wedge 2-Step 2</arm_group_label>
    <arm_group_label>Wedge 3- Step 2</arm_group_label>
    <arm_group_label>Wedge 3- Step 3</arm_group_label>
    <arm_group_label>Wedge 3-Step 1</arm_group_label>
    <arm_group_label>Wedge 4- Step 2</arm_group_label>
    <arm_group_label>Wedge 4-Step 1</arm_group_label>
    <arm_group_label>Wedge 4-Step 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NYU and/or Bellevue patient

          -  Diagnosed with HTN and pre-diabetes/diabetes

          -  Must be English speakers

          -  Ownership of a smart phone and are willing to use it to download app built in TrialX
             which will be free for participants

          -  Must be ambulatory

        Exclusion Criteria:

          -  are unable or unwilling to provide informed consent;

          -  are unable to participate meaningfully in an intervention that involves
             self-monitoring using software available in English (e.g., due to uncorrected sight
             impairment, illiterate, non-English-speaking, dementia);

          -  are pregnant, are currently trying to become pregnant, or who become pregnant during
             the study

          -  are institutionalized (e.g., in a nursing home or personal care facility, or those who
             are incarcerated and have limited control over self-management)

          -  have had or are planning to have bariatric surgery during the study

          -  have a history of heart disease, kidney disease, or retinopathy (to rule-out those
             with long-standing, undiagnosed T2D)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Azizi Seixas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shannique K Richards</last_name>
    <phone>732-693-8081</phone>
    <email>Shannique.Richards@nyulangone.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Shannique Richards</last_name>
      <phone>732-693-8081</phone>
      <email>Shannique.Richards@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Azizi Seixas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 21, 2018</study_first_submitted>
  <study_first_submitted_qc>August 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>January 6, 2020</last_update_submitted>
  <last_update_submitted_qc>January 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting requests and accessing data may be found at (Link to be provided).</ipd_time_frame>
    <ipd_access_criteria>Investigators whose proposed use of the data has been approved by an independent review committee (&quot;learned intermediary&quot;) identified for this purpose.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

